Relationship between Vitamin D, Inflammation and Lung Function In Patients with Severe Uncontrolled Asthma
DOI:
https://doi.org/10.3889/oamjms.2017.190Keywords:
asthma, Vitamin D, IL-33, FEV1, Th2-type cytokinesAbstract
BACKGROUND: Recently epidemiological studies showed that low vitamin D is linked to airway hyperresponsiveness, decreased lung function, poor asthma control, and steroid–resistant asthma.
AIM: We investigated the relationship between Vitamin D, inflammation with circulating IL-33 and lung function in 30 patients with severe uncontrolled asthma.
MATERIALS AND METHODS: The study included 30 patients with severe uncontrolled asthma. In each of them were measured serum levels of IL-33 and Vitamin D by the ELISA method. The pulmonary function is measured by basic spirometry parameters, FEV1. The results were statistically elaborated according to the Pearson’s Correlation Tests.
RESULTS: The results showed statistically insignificant correlation between Vitamin D and IL-33, and Vitamin D with FEV1 (Vit.D/IL-33; r = 0.11323, p = 0.551); (Vit.D/FEV1; r = -0.1005; p = 0.597) Correlation between IL-33 and FEV1 is negative but statistically significant (IL-33/FEV1; r = -0.5248; p = 0.003).
CONCLUSION: Because there are little studies about the link between vitamin D and asthma, further research to clarify the mechanism how vitamin D control the activity of CD4+ T cells and the related Th2-type cytokines in the parthenogenesis of asthma.Downloads
Metrics
Plum Analytics Artifact Widget Block
References
Masoli M, Fabian D, Holt S, Beasley R. The global burden of asthma: executive summary of the GINA Dissemination Committee report. Allergy. 2004; 59(5): 469-478. https://doi.org/10.1111/j.1398-9995.2004.00526.x PMid:15080825
Beasley R. The Global Burden of Asthma Report, Global Initiative for Asthma (GINA). Available from http://www.ginasthma.org 2004.
World Health Organization. Global surveillance, prevention and control of chronic respiratory diseases: a comprehensive approach, 2007.
Centers for Disease Control and Prevention, Vital Signs, May 2011.
Gjorcev A. Makedonski nacionalen plan i program za dijag-nostikai lekuvanje na bronhilajnata asthma-realnost i vizija, 1996.
Vladimir Cvetanov. Alergiskite bolesti vo R. Makedonija, 2006: 151-174.
Global Initiative for Asthma (GINA), GINA Report 2017, Global Strategy for Asthma Management and Prevention updated 2017. http://www.ginasthma.org
Holgate ST. Genetic and environmental interaction in Allergy and asthma. J Allergy Clin Immunol. 1999; 104(6): 1139-1146. https://doi.org/10.1016/S0091-6749(99)70005-9
Thomas MJ, Kemeny DM. Novel CD4 and CDS T-cell subsets. Allergy. 1998; 53: 1122-1132. https://doi.org/10.1111/j.1398-9995.1998.tb03831.x
Heard BE, Hossain S. Hyperplasia of bronchial muscle in asthma. J Pathol. 1973; 110: 319-331. https://doi.org/10.1002/path.1711100406
Shiels IA, Bowler SD, Taylor SM. Airway smooth muscle proliferation in asthma: the potential of vascular leakage to contribute to pathogenesis. Med Hypotheses. 1995; 45: 37-40. https://doi.org/10.1016/0306-9877(95)90198-1
Dirkje S Postma, Wim Timens. Remodeling in Asthma and Chronic Obstructive Pulmonary Disease. American Thoracic Society. 2006; 3(5): 434-439. https://doi.org/10.1513/pats.200601-006AW PMid:16799088
Christopher L. Grainge, Laurie C.K. Lau, Jonathon A. Ward, et al. Effect of bronchoconstriction on Airway Remodeling in Asthma. N Engl J Med. 2011; 364: 2006-2015. https://doi.org/10.1056/NEJMoa1014350 PMid:21612469
Barnes PJ. Pathophysiology of asthma. Eur Respir Mon. 2003; 23: 84-113.
Kuipers H, Lambrecht BN. The interplay of dendritic cells, Th2cells and regulatory T cells in asthma. Curr Opin Immunol. 2004; 16(6): 702-708. https://doi.org/10.1016/j.coi.2004.09.010 PMid:15511661
Abbas AK, Lichtman Ah, Pober JS. Cellular and Molecular Immunology. 4th ed., 2000: 235-69.
Roitt IM, and Delves PJ. Essential Immunology, 10th ed., 2001: 177-199.
Larche M, Robinson DS, Kay AB. The role of T lymphocytes in the pathogenesis of asthma. J Allergy Clin Immunol. 2003;111: 450-463. https://doi.org/10.1067/mai.2003.169 PMid:12642820
Zhu J, Hidehiro Y, William EP. Differentiation of effector CD4 T cell populations. Annu Rev Immunol. 2010;28: 445-489. https://doi.org/10.1146/annurev-immunol-030409-101212 PMid:20192806 PMCid:PMC3502616
Borish L, Steinke JW. Interleukin-33 in asthma: how big of a role does it play? Curr Allergy Asthma Rep. 2011; 11: 7-11. https://doi.org/10.1007/s11882-010-0153-8 PMid:20931364 PMCid:PMC3068600
Schmitz J, Owyang A, Oldham E., et al. et al. IL-33, an interleukin-1-like cytokine that signals via the IL-1 receptor-related protein ST2 and induces T-helper type 2-associated cytokines. Immunity. 2005; 23: 479-490. https://doi.org/10.1016/j.immuni.2005.09.015 PMid:16286016
Kakkar R, Lee RT. The IL-33/ST2 pathway: therapeutic target and novel biomarker. Nat Rev Drug Discov 2008; 7: 827-840. https://doi.org/10.1038/nrd2660 PMid:18827826 PMCid:PMC4277436
Miller AM. Role of IL-33 in inflammation and disease. J Inflamm. 2011; 8: 22. https://doi.org/10.1186/1476-9255-8-22 PMid:21871091 PMCid:PMC3175149
Anna Bonanno, Sebastiano G. Stefania La G. at al. 25-Hydroxyvitamin D, IL-31, and IL-33 in Children with Allergic Disease of the Airways Mediators Inflamm. 2014; 2014: ID 520241
Benson AA, Toh JA, Vernon N, Jariwala SP. The role of vitamin D in the immunopathogenesis of allergic skin diseases. Allergy. 2012;67(3):296–301. https://doi.org/10.1111/j.1398-9995.2011.02755.x PMid:22171613
Annesi-Maesano I. Perinatal events, vitamin D, and the development of allergy. Pediatric Research. 2002;52(1):3–5. https://doi.org/10.1203/01.PDR.0000017228.29635.EF
Meyts I., Hellings PW, Hens G. et al. IL-12 contributes to allergen-induced airway inflammation in experimental asthma. Journal of Immunology. 2006;177(9):6460–6470. https://doi.org/10.4049/jimmunol.177.9.6460
Matheu V, Bäck O, Mondoc E, Issazadeh-Navikas S. Dual effects of vitamin D-induced alteration of TH1/TH2 cytokine expression: enhancing IgE production and decreasing airway eosinophilia in murine allergic airway disease. The Journal of Allergy and Clinical Immunology. 2003;112(3):585–592. https://doi.org/10.1016/S0091-6749(03)01855-4
Wu AC, Kelan T, Lingling L, et al. The effect of vitamin D and inhaled corticosteroid treatment on lung function in children. Am J Respir Crit. Care Med. 2012; 186(6):508-513. https://doi.org/10.1164/rccm.201202-0351OC PMid:22798322 PMCid:PMC3480528
Hala Mohamed ShS, Amany RE, Eman N. Vitamin D and markers of airway inflammation in asthma. Egyptian Journal of Chest Diseases and Tuberculosis. 2015; 64:779–783. https://doi.org/10.1016/j.ejcdt.2015.03.027
Clinical Pulmonary Function Testing, Exercise Testing, and Disability Evaluation. In Chest Medicine: Essentials Of Pulmonary And Critical Care Medicine. 5th edition. Editors: George RB, Light RW, Matthay RA, Matthay MA, May 2005.
Miller MR, Hankinson J, Brusasco V, et al. Standardisation of spirometry. Eur Respir J. 2005;26:319-338. https://doi.org/10.1183/09031936.05.00034805 PMid:16055882
National Asthma Education, Prevention Program (National Heart, Lung, Blood Institute). Second Expert Panel on the Management of Asthma. Expert panel report 2: Guidelines for the diagnosis and management of asthma. DIANE Publishing; 1998.
Chung KF, Wenzel SE, Brozek JL, Bush A, Castro M, Sterk PJ, Adcock IM, Bateman ED, Bel EH, Bleecker ER, Boulet LP. International ERS/ATS guidelines on definition, evaluation and treatment of severe asthma. European Respiratory Journal. 2013:erj02020-2013.
Sandhu MS, Casale TB. The role of vitamin D in asthma. Ann Allergy Asthma Immunol. 2010; 105:191-199. https://doi.org/10.1016/j.anai.2010.01.013 PMid:20800785
Stephanie K, Hübner M, Matthias J, Maria B, Roland B. Severe and uncontrolled adult asthma is associated with vitamin D insufficiency and deficiency, Respir Res. 2013; 14:25. https://doi.org/10.1186/1465-9921-14-25 PMid:23432854 PMCid:PMC3648461
Bischoff-Ferrari HA, Giovannucci E, Willett WC, Dietrich T, Dawson-Hughes B. Estimation of optimal serum concentrations of 25-hydroxyvitamin D for multiple health outcomes. Am J Clin Nutr. 2006;84:18-28. PMid:16825677
Felicia Montero-Arias,Giovanni Sedó-MejÃa, Allan Ramos-Esquivel. Vitamin D Insufficiency and Asthma Severity in Adults From Costa Rica. Allergy Asthma Immunol Res. 2013;5(5):283-288. https://doi.org/10.4168/aair.2013.5.5.283 PMid:24003384 PMCid:PMC3756174
Matheu V, Bäck O, Mondoc E, Issazadeh-Navikas S. Dual effects of vitamin D-induced alteration of TH1/TH2 cytokine expression: enhancing IgE production and decreasing airway eosinophilia in murine allergic airway disease. J Allergy Clin Immunol 2003;112:585-92. https://doi.org/10.1016/S0091-6749(03)01855-4
Sutherland ER, Goleva E, Jackson LP, Stevens AD, Leung DY. Vitamin D levels, lung function, and steroid response in adult asthma. Am J Respir Crit Care Med. 2010;181:699-704. https://doi.org/10.1164/rccm.200911-1710OC PMid:20075384 PMCid:PMC2868500
Lange NE, Litonjua A, Hawrylowicz CM, Weiss S. Vitamin D, the immune system and asthma. Expert Rev Clin Immunol. 2009;5:693-702. https://doi.org/10.1586/eci.09.53 PMid:20161622 PMCid:PMC2812815
Larose TL, Arnulf L, Yue Chen, et al. Serum 25-hydroxyvitamin D levels and lung function in adults with asthma: the HUNT Study. Eur Respir J. 2015;45(4):1019-26. https://doi.org/10.1183/09031936.00069714 PMid:25395037
Laura T, Edita G, Simona L, et al. Evaluation of vitamin D levels in allergic and non-allergic asthma. Medicine. 2015; 51(6):321-327. https://doi.org/10.1016/j.medici.2015.11.003 PMid:26739673
Lin Z, Li W. The roles of vitamin D and its analogues in inflammatory diseases. Current topics in medicinal chemistry. 2016;16(11):1242-61. https://doi.org/10.2174/1568026615666150915111557 PMid:26369816
Li YM, Cheng XM. Clinical significance of IL-18 and IL-33 levels changes in the treatment of bronchial asthma with acute attack stage by glucocorticoids. Practical Pharmacy and Clinical Remedies. 2013; 16: 897-9.
Azazi EA, Elshora AE, Tantawy EA, Elsayd MA. Serum levels of Interleukin-33 and its soluble receptor ST2 in asthmatic patients. Egyptian Journal of Chest Diseases and Tuberculosis. 2014;63(2):279-84. https://doi.org/10.1016/j.ejcdt.2013.11.005
Liu SP, Ma R, Li XA. The relationship between interleukin 33 promotes and lung inflammation in asthmatic children. Chin J Diffic and Compl Cas. 2013; 12:422-4.
Préfontaine D, Nadigel J, Chouiali F, et al. Increased IL-33 expression by epithelial cells in bronchial asthma. J Allergy Clin Immunol. 2010; 125: 752-4. https://doi.org/10.1016/j.jaci.2009.12.935 PMid:20153038
Préfontaine D. Lajoie-Kadoch S, Foley Set al. Increased expression of IL-33 in severe asthma: evidence of expression by airway smooth muscle cells. J Immunol. 2009; 183: 5094-103. https://doi.org/10.4049/jimmunol.0802387 PMid:19801525
Liao XM. Changes of plasma interleukin 33 in asthmatic patients and its clinical significance. Journal of Clinical Pulmonary Medicine. 2014; 19: 33-5.
Downloads
Published
How to Cite
Issue
Section
License
http://creativecommons.org/licenses/by-nc/4.0